This year, SOM Biotech was invited to present to the Investors Circle of the Business Angel Network of BIO.NRW on the 9th of July in Dusseldorf, Germany. SOM Biotech CEO Dr. Raúl Insa presented the company, highlighting its proven business model to the attending investors. The presentation platform is held three to four times a year in a strictly confidential…
SOM Biotech presents to the BIO.NRW Investors Circle
posted on July 10, 2018
SOM Biotech receives approval to start Huntington’s disease trial
posted on June 22, 2018
SOM Biotech has received on 18th June 2018 the approval of the Clinical Trial Application (CTA), the European IND equivalent, from the Spanish Drug Agency (AEMPS) to conduct its Phase IIa, double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of SOM3355 in patients with choreic movements associated with Huntington's disease. The study will be conducted in four major hospitals in…
SOM Biotech at Trifermed Awards 2018
posted on June 19, 2018
The third edition of Trifermed Awards for Social Impact in Healthcare was held on 14th June 2018 at the CaixaForum in Barcelona, Spain. The Trifermed Awards is a ceremony that recognizes motivated individuals and organizations that aim to improve the quality of healthcare in the society, with the common goal of developing a better world. According to Prof. Dr. Sergi…
1st National Congress on Muscular Dystrophy of Duchenne & Becker 2018
posted on May 28, 2018
Parent Project España organized the 1st Congreso Nacional Duchenne which was held last 25th-27th May 2018 in Madrid. It aimed to help families and those affected gain access to the exchange of information and experiences in order to encourage mutual support and learn about the different aspects of Muscular Dystrophy of Duchenne and Becker. The congress mainly analyzed the…
SOM Biotech at Outsourcing in Clinical Trials Europe 2018
posted on May 17, 2018
The 8th Annual Outsourcing in Clinical Trials Europe 2018 was held last 15th-16th May 2018 in Barcelona, Spain. It is the leading clinical trial outsourcing conference in Europe which aims to promote better collaboration between trial sponsors and solution providers, and provide attendees with practical take-aways that can be applied to their own operations. SOM Biotech Clinical Operations…
SOM Biotech at Genesis Drug Discovery 2018
posted on May 14, 2018
The 2nd Annual Genesis Drug Discovery Conference was held last 10th-11th May 2018 in Barcelona, Spain. SOM Biotech CEO, Dr. Raúl Insa, gave an interesting talk on the "Systematic Drug Repurposing Discovery" wherein he discussed about drug repurposing and its advantages, and SOM Biotech's technology, programs and business model. Dr. Raúl Insa during his session @ Genesis Drug Discovery…